(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.99%) $83.02
(-1.16%) $1.619
(-0.38%) $2 338.30
(-0.45%) $27.41
(0.54%) $927.10
(-0.14%) $0.933
(-0.12%) $11.01
(-0.22%) $0.799
(0.00%) $92.17
18.23% £ 4.15
Live Chart Being Loaded With Signals
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union...
Stats | |
---|---|
Volumen de hoy | 423 867 |
Volumen promedio | 149 345 |
Capitalización de mercado | 12.25M |
EPS | £0 ( 2024-04-02 ) |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | -4.15 |
ATR14 | £0 (0.00%) |
Proteome Sciences PLC Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Proteome Sciences PLC Finanzas
Annual | 2023 |
Ingresos: | £23.50B |
Beneficio Bruto: | £23.49B (99.99 %) |
EPS: | £0.270 |
FY | 2023 |
Ingresos: | £23.50B |
Beneficio Bruto: | £23.49B (99.99 %) |
EPS: | £0.270 |
FY | 2022 |
Ingresos: | £23.74B |
Beneficio Bruto: | £23.73B (99.99 %) |
EPS: | £17.02 |
FY | 2021 |
Ingresos: | £5.13M |
Beneficio Bruto: | £2.96M (57.71 %) |
EPS: | £0.000240 |
Financial Reports:
No articles found.
Proteome Sciences PLC
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union. The company offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the important factor. It also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers. In addition, the company offers bioinformatics tools, including Proteome Discoverer for peptide sequence and TMT quantitation; SQuaT,CalDIT, and DIANA for normalized quantitative values and functional annotation at peptide and protein level; FeaST for visualization of data quality, class identifier model, and biomarker candidate lists; and FAT for identification of biological processes and cellular components showing variance. It primarily serves pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico